Late-emerging strains of HIV induce T-cell homeostasis failure by promoting bystander cell death and immune exhaustion in naïve CD4 and all CD8 T-cells

Medical Hypotheses

Volumn 83, Issue 1, 2014, Pages 69-73

  Kibirige, Catherine N ^a   Menendez, Frederick A ^a   Zhang, Hao ^a   Nilles, Tricia L ^a   Langan, Susan ^a   Margolick, Joseph B ^a  

^a JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ARTICLE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL COUNT; CELL DEATH; DISEASE COURSE; HOMEOSTASIS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; IMMUNE DYSREGULATION; IMMUNOTHERAPY; LYMPHOCYTE FUNCTION; MEMORY T LYMPHOCYTE; T CELL DEPLETION; VIRION; VIRUS STRAIN; BYSTANDER EFFECT; IMMUNOLOGY; PATHOLOGY; PHYSIOLOGY; T LYMPHOCYTE;

BYSTANDER EFFECT; CELL DEATH; HIV; HOMEOSTASIS; HUMANS; T-LYMPHOCYTES;

EID: 84901048819     PISSN: 03069877     EISSN: 15322777     Source Type: Journal    
DOI: 10.1016/j.mehy.2014.04.005     Document Type: Article

References (63)

1. Adleman L.M., Wofsy D. Blind T-cell homeostasis in CD4-deficient mice. J Acquir Immune Defic Syndr Hum Retrovirol 1996, 11:334-340.
2. Adleman L.M., Wofsy D. T-cell homeostasis: implications in HIV infection. J Acquir Immune Defic Syndr 1993, 6:144-152.
3. Fevrier M., Dorgham K., Rebollo A. CD4+ T cell depletion in human immunodeficiency virus (HIV) infection: role of apoptosis. Viruses 2011, 3:586-612.
4. Galai N., Margolick J.B., Astemborski J., Vlahov D. Existence and failure of T-cell homeostasis prior to AIDS onset in HIV-infected injection drug users. Clin Immunol Immunopathol 1996, 79:134-141.
5. Gange S.J., Munoz A., Chmiel J.S., et al. Identification of inflections in T-cell counts among HIV-1-infected individuals and relationship with progression to clinical AIDS. Proc Natl Acad Sci USA 1998, 95:10848-10853.
6. Maas J.J., Gange S.J., Schuitemaker H., Coutinho R.A., van Leeuwen R., Margolick J.B. Strong association between failure of T cell homeostasis and the syncytium-inducing phenotype among HIV-1-infected men in the Amsterdam Cohort Study. AIDS 2000, 14:1155-1161.
7. Margolick J.B., Donnenberg A.D., Munoz A., et al. Changes in T and non-T lymphocyte subsets following seroconversion to HIV-1: stable CD3+ and declining CD3- populations suggest regulatory responses linked to loss of CD4 lymphocytes. The Multicenter AIDS Cohort Study. J Acquir Immune Defic Syndr 1993, 6:153-161.
8. Margolick J.B., Munoz A., Donnenberg A.D., et al. Failure of T-cell homeostasis preceding AIDS in HIV-1 infection. The Multicenter AIDS Cohort Study. Nat Med 1995, 1:674-680.
9. Koot M., Keet I.P., Vos A.H., et al. Prognostic value of HIV-1 syncytium-inducing phenotype for rate of CD4+ cell depletion and progression to AIDS. Ann Intern Med 1993, 118:681-688.
10. Shepherd J.C., Jacobson L.P., Qiao W., et al. Emergence and persistence of CXCR4-tropic HIV-1 in a population of men from the multicenter AIDS cohort study. J Infect Dis 2008, 198:1104-1112.
11. Waters L., Mandalia S., Randell P., Wildfire A., Gazzard B., Moyle G. The impact of HIV tropism on decreases in CD4 cell count, clinical progression, and subsequent response to a first antiretroviral therapy regimen. Clin Infect Dis 2008, 46:1617-1623.
12. Piatak M., Saag M.S., Yang L.C., et al. High levels of HIV-1 in plasma during all stages of infection determined by competitive PCR. Science 1993, 259:1749-1754.
13. Rossio J.L., Esser M.T., Suryanarayana K., et al. Inactivation of human immunodeficiency virus type 1 infectivity with preservation of conformational and functional integrity of virion surface proteins. J Virol 1998, 72:7992-8001.
14. Roederer M., Dubs J.G., Anderson M.T., Raju P.A., Herzenberg L.A., Herzenberg L.A. CD8 naive T cell counts decrease progressively in HIV-infected adults. J Clin Invest 1995, 95:2061-2066.
15. Gulzar N., Diker B., Mihowich J., et al. Proportion of HIV-1 infected CD8+CD4- T lymphocytes in vivo. Curr HIV Res 2008, 6:585-596.
16. McBreen S., Imlach S., Shirafuji T., et al. Infection of the CD45RA+ (naive) subset of peripheral CD8+ lymphocytes by human immunodeficiency virus type 1 in vivo. J Virol 2001, 75:4091-4102.
17. Badley A.D., Pilon A.A., Landay A., Lynch D.H. Mechanisms of HIV-associated lymphocyte apoptosis. Blood 2000, 96:2951-2964.
18. Carbonari M., Pesce A.M., Cibati M., et al. Death of bystander cells by a novel pathway involving early mitochondrial damage in human immunodeficiency virus-related lymphadenopathy. Blood 1997, 90:209-216.
19. Che K.F., Sabado R.L., Shankar E.M., et al. HIV-1 impairs in vitro priming of naive T cells and gives rise to contact-dependent suppressor T cells. Eur J Immunol 2010, 40:2248-2258.
20. Doitsh G., Cavrois M., Lassen K.G., et al. Abortive HIV infection mediates CD4 T cell depletion and inflammation in human lymphoid tissue. Cell 2010, 143:789-801.
21. Espert L., Varbanov M., Robert-Hebmann V., et al. Differential role of autophagy in CD4 T cells and macrophages during X4 and R5 HIV-1 infection. PLoS One 2009, 4:e5787.
22. Finkel T.H., Tudor-Williams G., Banda N.K., et al. Apoptosis occurs predominantly in bystander cells and not in productively infected cells of HIV- and SIV-infected lymph nodes. Nat Med 1995, 1:129-134.
23. Ahr B., Robert-Hebmann V., Devaux C., Biard-Piechaczyk M. Apoptosis of uninfected cells induced by HIV envelope glycoproteins. Retrovirology 2004, 1:12.
24. Garg H., Blumenthal R. Role of HIV Gp41 mediated fusion/hemifusion in bystander apoptosis. Cell Mol Life Sci 2008, 65:3134-3144.
25. Molina L., Grimaldi M., Robert-Hebmann V., et al. Proteomic analysis of the cellular responses induced in uninfected immune cells by cell-expressed X4 HIV-1 envelope. Proteomics 2007, 7:3116-3130.
26. Smith D.S., Guo K., Barrett B.S., et al. Noninfectious retrovirus particles drive the APOBEC3/Rfv3 dependent neutralizing antibody response. PLoS Pathog 2011, 7:e1002284.
27. Chattopadhyay P.K., Douek D.C., Gange S.J., Chadwick K.R., Hellerstein M., Margolick J.B. Longitudinal assessment of de novo T cell production in relation to HIV-associated T cell homeostasis failure. AIDS Res Hum Retroviruses 2006, 22:501-507.
28. Esser M.T., Bess J.W., Suryanarayana K., et al. Partial activation and induction of apoptosis in CD4(+) and CD8(+) T lymphocytes by conformationally authentic noninfectious human immunodeficiency virus type 1. J Virol 2001, 75:1152-1164.
29. Arthur L.O., Bess J.W., Chertova E.N., et al. Chemical inactivation of retroviral infectivity by targeting nucleocapsid protein zinc fingers: a candidate SIV vaccine. AIDS Res Hum Retroviruses 1998, 14(Suppl. 3):S311-S319.
30. Keet I.P., Krol A., Koot M., et al. Predictors of disease progression in HIV-infected homosexual men with CD4+ cells < 200×10(6)/l but free of AIDS-defining clinical disease. AIDS 1994, 8:1577-1583.
31. Gange S.J., Lau B., Phair J., Riddler S.A., Detels R., Margolick J.B. Rapid declines in total lymphocyte count and hemoglobin in HIV infection begin at CD4 lymphocyte counts that justify antiretroviral therapy. AIDS 2003, 17:119-121.
32. Levy J.A. Virus-host interactions in HIV pathogenesis: directions for therapy. Adv Dent Res 2011, 23:13-18.
33. Chalmet K., Dauwe K., Foquet L., et al. Presence of CXCR4-using HIV-1 in patients with recently diagnosed infection: correlates and evidence for transmission. J Infect Dis 2012, 205:174-184.
34. Yang Y., Al-Mozaini M., Buzon M.J., et al. CD4 T-cell regeneration in HIV-1 elite controllers. AIDS 2012, 26:701-706.
35. Genesca M. Characterization of an effective CTL response against HIV and SIV infections. J Biomed Biotechnol 2011, 2011:103924.
36. Walsh A.D., Bimber B.N., Das A., et al. Acute phase CD8+ T lymphocytes against alternate reading frame epitopes select for rapid viral escape during SIV infection. PLoS One 2013, 8:e61383.
37. Schmitz J.E., Kuroda M.J., Santra S., et al. Control of viremia in simian immunodeficiency virus infection by CD8+ lymphocytes. Science 1999, 283:857-860.
38. Walker U.A., Warnatz K. Idiopathic CD4 lymphocytopenia. Curr Opin Rheumatol 2006, 18:389-395.
39. McDermott A.B., Koup R.A. CD8(+) T cells in preventing HIV infection and disease. AIDS 2012, 26:1281-1292.
40. Eichbaum Q. PD-1 signaling in HIV and chronic viral infection - potential for therapeutic intervention?. Curr Med Chem 2011, 18:3971-3980.
41. Catherine Kibirige J.M. Non-infectious CXCR4-tropic HIV induces T-Cell death and possibly AIDS 2010, Lambert Academic Publishing AG & Co. KG, Dudweiler Landstr. 99, 66123 Saarbucken, Germany.
42. Choudhary S.K., Walker R.M., Powell D.M., Planelles V., Walsh C., Camerini D. CXCR4 tropic human immunodeficiency virus type 1 induces an apoptotic cascade in immature infected thymocytes that resembles thymocyte negative selection. Virology 2006, 352:268-284.
43. Kitchen S.G., Zack J.A. CXCR4 expression during lymphopoiesis: implications for human immunodeficiency virus type 1 infection of the thymus. J Virol 1997, 71:6928-6934.
44. Yang L.P., Riley J.L., Carroll R.G., et al. Productive infection of neonatal CD8+ T lymphocytes by HIV-1. J Exp Med 1998, 187:1139-1144.
45. Kitchen S.G., Korin Y.D., Roth M.D., Landay A., Zack J.A. Costimulation of naive CD8(+) lymphocytes induces CD4 expression and allows human immunodeficiency virus type 1 infection. J Virol 1998, 72:9054-9060.
46. Hoffman T.L., LaBranche C.C., Zhang W., et al. Stable exposure of the coreceptor-binding site in a CD4-independent HIV-1 envelope protein. Proc Natl Acad Sci USA 1999, 96:6359-6364.
47. Kaslow R.A., Ostrow D.G., Detels R., Phair J.P., Polk B.F., Rinaldo C.R. The Multicenter AIDS Cohort Study: rationale, organization, and selected characteristics of the participants. Am J Epidemiol 1987, 126:310-318.
48. Carriere I., Bouyer J. Choosing marginal or random-effects models for longitudinal binary responses: application to self-reported disability among older persons. BMC Med Res Methodol 2002, 2:15.
49. Gupta S.B., Jacobson L.P., Margolick J.B., et al. Estimating the benefit of an HIV-1 vaccine that reduces viral load set point. J Infect Dis 2007, 195:546-550.
50. Noraz N., Gozlan J., Corbeil J., Brunner T., Spector S.A. HIV-induced apoptosis of activated primary CD4+ T lymphocytes is not mediated by Fas-Fas ligand. AIDS 1997, 11:1671-1680.
51. Kishore M., Ma L., Cornish G., Nourshargh S., Marelli-Berg F.M. Primed T cell responses to chemokines are regulated by the immunoglobulin-like molecule CD31. PLoS One 2012, 7:e39433.
52. Chitnis V., Pahwa R., Pahwa S. Determinants of HIV-specific CD8 T-cell responses in HIV-infected pediatric patients and enhancement of HIV-gag-specific responses with exogenous IL-15. Clin Immunol 2003, 107:36-45.
53. Herbein G., Mahlknecht U., Batliwalla F., et al. Apoptosis of CD8+ T cells is mediated by macrophages through interaction of HIV gp120 with chemokine receptor CXCR4. Nature 1998, 395:189-194.
54. Okazaki T., Honjo T. PD-1 and PD-1 ligands: from discovery to clinical application. Int Immunol 2007, 19:813-824.
55. Denizot M., Varbanov M., Espert L., et al. HIV-1 gp41 fusogenic function triggers autophagy in uninfected cells. Autophagy 2008, 4:998-1008.
56. Margolick J.B., Imteyaz H., Gallant J.E., et al. Prolonged viral suppression without therapy in an HIV-1 seroconverter following early antiretroviral therapy and daily interleukin-2. AIDS 2010, 24:932-935.
57. Butler S.L., Valdez H., Westby M., et al. Disease-modifying therapeutic concepts for HIV in the era of highly active antiretroviral therapy. J Acquir Immune Defic Syndr 2011, 58:297-303.
58. Lewin S.R., Rouzioux C. HIV cure and eradication: how will we get from the laboratory to effective clinical trials?. AIDS 2011, 25:885-897.
59. Hutter G., Schneider T., Thiel E. Transplantation of selected or transgenic blood stem cells - a future treatment for HIV/AIDS?. J Int AIDS Soc 2009, 12. (10-2652-12-10).
60. Hutter G., Nowak D., Mossner M., et al. Long-term control of HIV by CCR5 Delta32/Delta32 stem-cell transplantation. N Engl J Med 2009, 360:692-698.
61. Mudd P.A., Martins M.A., Ericsen A.J., et al. Vaccine-induced CD8+ T cells control AIDS virus replication. Nature 2012, 491:129-133.
62. Chun T.W., Justement J.S., Murray D., et al. Rebound of plasma viremia following cessation of antiretroviral therapy despite profoundly low levels of HIV reservoir: implications for eradication. AIDS 2010, 24:2803-2808.
63. Rasmussen T.A., Schmeltz Sogaard O., Brinkmann C., et al. Comparison of HDAC inhibitors in clinical development: Effect on HIV production in latently infected cells and T-cell activation. Hum Vaccine Immunother 2013, 9.